Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people whoโ€™ve been there
  • People who understand what youโ€™re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLymphomaTeam Member asked a question ๐Ÿ’ญ
Ashland City, TN

Mantle cell lymphoma, in remission 16 months, God has blessed me with remission. My ki 20% .. it could have been so much worse. Tp53<5%

January 14 (edited)
 · 
Reactions
A MyLymphomaTeam Member

Iโ€™m so happy your in remission god bless ๐Ÿ˜Š

January 14
A MyLymphomaTeam Member

Thank you so much.

January 15
MyLymphomaTeam

What are the worst biomarkers for mantle cell lymphoma?

Congratulations on your 16-month remission - that's wonderful news! Your Ki-67 at 20% is indeed on the lower side, which is a positive sign.

The most concerning biomarkers for mantle cell lymphoma include:

* TP53 mutation - This is considered one of the worst Show Full Answer

What are the worst biomarkers for mantle cell lymphoma?

Congratulations on your 16-month remission - that's wonderful news! Your Ki-67 at 20% is indeed on the lower side, which is a positive sign.

The most concerning biomarkers for mantle cell lymphoma include:

* TP53 mutation - This is considered one of the worst biomarkers as it indicates the disease may be resistant to chemotherapy and behave more aggressively
* High Ki-67 proliferation index - Higher percentages (typically above 30%) suggest more aggressive disease, so your 20% is relatively favorable
* Blastoid or pleomorphic variants - These subtypes tend to be more aggressive

The TP53 mutation is particularly significant because it can affect both treatment response and disease behavior. It's similar to what's seen in other lymphomas where it indicates potential treatment resistance.

Your medical team likely assessed these markers at diagnosis to help guide your treatment plan. Since you're in remission, it's important to continue with regular follow-up appointments to monitor for any changes.

January 14

Related Questions

View All
A MyLymphomaTeam Member asked a question ๐Ÿ’ญ
Australia

A MyLymphomaTeam Member asked a question ๐Ÿ’ญ
Ashland City, TN

A MyLymphomaTeam Member asked a question ๐Ÿ’ญ
Australia